Transcriptional targets of the vitamin D3 receptor-mediating cell cycle arrest and differentiation.

We are exploring the mechanism of action of the hormonal form of the nutrient vitamin D, 1,25(OH)2D3, and its cognate nuclear receptor at the level of gene control. In doing so, we have focused on a dual track as follows: 1) to define the vitamin D3 receptor (VDR) function and structure by examining its various actions at the molecular level; and 2) to isolate and characterize VDR target genes that might be playing key roles in mediating vitamin D growth suppression and differentiation in responsive cells, specifically, the elucidation of vitamin D target genes as they relate to myeloid differentiation. Here, we will summarize some of our recent results from both tracks because a detailed understanding of how VDR functions as a ligand-regulated transcription factor will allow us to study its actions on these newly discovered genes more effectively.

[1]  L. Freedman,et al.  DNA sequences that act as high affinity targets for the vitamin D3 receptor in the absence of the retinoid X receptor. , 1994, Molecular endocrinology.

[2]  P. Reitsma,et al.  Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[3]  S. Collins,et al.  Terminal Differentiation of Human Promyelocytic Leukemic Cells in Primary Culture in Response to Retinoic Acid , 1981 .

[4]  E. C. Anderson,et al.  A Differential Screen for Ligand-Regulated Genes: Identification of HoxA10 as a Target of Vitamin D3 Induction in Myeloid Leukemic Cells , 1998, Molecular and Cellular Biology.

[5]  L. Freedman,et al.  Modulation of nuclear receptor interactions by ligands: kinetic analysis using surface plasmon resonance. , 1996, Biochemistry.

[6]  G. Sauvageau,et al.  Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells. , 1995, Experimental hematology.

[7]  P. Lomedico,et al.  Vitamin D3-retinoid X receptor dimerization, DNA binding, and transactivation are differentially affected by analogs of 1,25-dihydroxyvitamin D3. , 1995, Molecular endocrinology.

[8]  H Zola,et al.  1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells. , 1983, Leukemia research.

[9]  D. Kufe,et al.  Expression of the jun-B gene during induction of monocytic differentiation. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[10]  James M. Roberts,et al.  Inhibitors of mammalian G1 cyclin-dependent kinases. , 1995, Genes & development.

[11]  H. Sakagami,et al.  Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[12]  H. DeLuca,et al.  1 alpha,25-dihydroxyvitamin D3 promotes fusion of mouse alveolar macrophages both by a direct mechanism and by a spleen cell-mediated indirect mechanism. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Collins,et al.  The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. , 1987, Blood.

[14]  G. Hannon,et al.  Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD , 1995, Science.

[15]  H. Erdjument-Bromage,et al.  A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system. , 1998, Genes & development.

[16]  H. Pitot,et al.  Transcriptional regulation of c-myc during chemically induced differentiation of HL-60 cultures. , 1985, Cancer research.

[17]  U. Gullberg,et al.  Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1 alpha,25-dihydroxycholecalciferol. , 1983, Cancer research.

[18]  L. Freedman,et al.  Retinoid X receptor:vitamin D3 receptor heterodimers promote stable preinitiation complex formation and direct 1,25-dihydroxyvitamin D3-dependent cell-free transcription , 1997, Molecular and cellular biology.

[19]  L. Freedman,et al.  Ligand modulates the conversion of DNA-bound vitamin D3 receptor (VDR) homodimers into VDR-retinoid X receptor heterodimers , 1994, Molecular and cellular biology.

[20]  James M. Roberts,et al.  p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. , 1994, Genes & development.

[21]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[22]  L. Freedman,et al.  Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. , 1996, Genes & development.

[23]  L. Freedman,et al.  Selective effects of ligands on vitamin D3 receptor- and retinoid X receptor-mediated gene activation in vivo , 1996, Molecular and cellular biology.

[24]  R. Eisenman,et al.  Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity , 1993, Cell.

[25]  L. Freedman,et al.  Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor , 1995, Molecular and cellular biology.

[26]  S. Collins,et al.  Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[27]  P. Reitsma,et al.  Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite , 1983, Nature.

[28]  S. Elledge,et al.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.

[29]  M. Haussler,et al.  A composite element binding the vitamin D receptor, retinoid X receptor alpha, and a member of the CTF/NF-1 family of transcription factors mediates the vitamin D responsiveness of the c-fos promoter , 1996, Molecular and cellular biology.

[30]  D. Solomon,et al.  Activation of the fructose 1,6-bisphosphatase gene by 1,25-dihydroxyvitamin D3 during monocytic differentiation. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[31]  L. Obeid,et al.  Transcriptional regulation of protein kinase C by 1,25-dihydroxyvitamin D3 in HL-60 cells. , 1990, The Journal of biological chemistry.

[32]  Z. Darżynkiewicz,et al.  Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells , 1989, Cell.

[33]  D. Kufe,et al.  Expression of the c-fms proto-oncogene during human monocytic differentiation , 1985, Nature.